Literature DB >> 16753485

Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis.

Carlos Nordt1, Rudolf Stohler.   

Abstract

BACKGROUND: Switzerland has been criticised for its liberal drug policy, which could attract new users and lengthen periods of heroin addiction. We sought to estimate incidence trends and prevalence of problem heroin use in Switzerland.
METHODS: We obtained information about first year of regular heroin use from the case register of substitution treatments in the canton of Zurich for 7256 patients (76% of those treated between 1991 and March, 2005). We estimated the proportion of heroin users not yet in substitution treatment programmes using the conditional lag-time distribution. Cessation rate was the proportion of individuals leaving substitution treatment programmes and not re-entering within the subsequent 10 years. Overall prevalence of problematic heroin use was modelled as a function of incidence and cessation rate.
FINDINGS: Every second person began their first substitution treatment within 2 years of starting to use heroin regularly. Incidence of heroin use rose steeply, starting with about 80 people in 1975, culminating in 1990 with 850 new users, and declining substantially to about 150 users in 2002. Two-thirds of those who had left substitution treatment programmes re-entered within the next 10 years. The population of problematic heroin users declined by 4% a year. The cessation rate in Switzerland was low, and therefore, the prevalence rate declined slowly. Our prevalence model accords with data generated by different approaches.
INTERPRETATION: The harm reduction policy of Switzerland and its emphasis on the medicalisation of the heroin problem seems to have contributed to the image of heroin as unattractive for young people. Our model could enable the study of incidence trends across different countries and thus urgently needed assessments of the effect of different drug policies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16753485     DOI: 10.1016/S0140-6736(06)68804-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

1.  Estimation of the Number of People With Opioid Addiction in Germany.

Authors:  Ludwig Kraus; Nicki-Nils Seitz; Bernd Schulte; Peter Cremer-Schaeffer; Barbara Braun; Uwe Verthein; Tim Pfeiffer-Gerschel
Journal:  Dtsch Arztebl Int       Date:  2019-03-01       Impact factor: 5.594

2.  Should drugs be decriminalised? Debate the balance of harm.

Authors:  Stephen Black
Journal:  BMJ       Date:  2007-11-24

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Should heroin be prescribed to heroin misusers? No.

Authors:  Neil McKeganey
Journal:  BMJ       Date:  2008-01-12

5.  Should heroin be prescribed to heroin misusers? Yes.

Authors:  Jürgen Rehm; Benedikt Fischer
Journal:  BMJ       Date:  2008-01-12

6.  Non-injection drug use patterns and history of injection among street youth.

Authors:  Scott E Hadland; Thomas Kerr; Brandon D L Marshall; William Small; Calvin Lai; Julio S Montaner; Evan Wood
Journal:  Eur Addict Res       Date:  2010-02-03       Impact factor: 3.015

7.  The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls.

Authors:  John Macleod; Lorraine Copeland; Matthew Hickman; James McKenzie; Jo Kimber; Daniela De Angelis; James R Robertson
Journal:  BMC Public Health       Date:  2010-02-26       Impact factor: 3.295

8.  Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.

Authors:  Ludwig Perger; Katharina M Rentsch; Gerd A Kullak-Ublick; Davide Verotta; Karin Fattinger
Journal:  Eur J Pharm Sci       Date:  2008-11-25       Impact factor: 4.384

9.  Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.

Authors:  Ulrike Halbsguth; Katharina M Rentsch; Dominique Eich-Höchli; Isabel Diterich; Karin Fattinger
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

10.  Estimating incidence trends in regular heroin use in 26 regions of Switzerland using methadone treatment data.

Authors:  Carlos Nordt; Karin Landolt; Rudolf Stohler
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.